Convalescent Plasma Therapy for Covid-19: State of the Art

Daniele Focosi; Julian Tang; Arthur Anderson; Marco Tuccori

doi:10.20944/preprints202004.0097.v7

Preprint Review Version 7 Preserved in Portico This version is not peer-reviewed

Version 1 : Received: 6 April 2020 / Approved: 7 April 2020 / Online: 7 April 2020 (11:47:15 CEST)
Version 2 : Received: 8 April 2020 / Approved: 8 April 2020 / Online: 8 April 2020 (11:43:14 CEST)
Version 3 : Received: 11 April 2020 / Approved: 13 April 2020 / Online: 13 April 2020 (10:56:12 CEST)
Version 4 : Received: 20 April 2020 / Approved: 22 April 2020 / Online: 22 April 2020 (09:50:33 CEST)
Version 5 : Received: 27 April 2020 / Approved: 28 April 2020 / Online: 28 April 2020 (09:37:10 CEST)
Version 6 : Received: 27 May 2020 / Approved: 28 May 2020 / Online: 28 May 2020 (11:52:38 CEST)
Version 7 : Received: 1 July 2020 / Approved: 1 July 2020 / Online: 1 July 2020 (14:12:21 CEST)

Convalescent blood product therapy has been introduced since early 1900s to treat emerging infectious disease based on the evidence that polyclonal neutralizing antibodies can reduce duration of viremia. Recent large outbreaks of viral diseases for whom effective antivirals or vaccines are still lacking has revamped the interest in convalescent plasma as life-saving treatments. This review summarizes historical settings of application, and surveys current technologies for collection, manufacturing, pathogen inactivation, and banking, with a focus on COVID-19.

convalescent plasma; serology; pathogen reduction technologies; pathogen inactivation; COVID-19; SARS-CoV2

Comment 1

Received: 1 July 2020
Commenter: Daniele Focosi
Commenter's Conflict of Interests: Author

Comment: Many more results from published clinical trials, improved Figure 1, updated references

+ Respond to this comment

Your full name

Your affiliation information (e.g., name of your university/institution/organization)

Not displayed online.

Your Email address (not made public)

Please leave your comment to this article below.

Mathematical equations can be typed in either LaTeX formats \\[ ... \\] or $$ ... $$, or MathML format <math> ... </math>. Try the LaTeX or MathML example.

Type equation:

Preview:

Copy equation into message below

Close menu

Please click a symbol to insert it into the message box below:

Please enter the link here:

Optionally, you can enter text that should appear as linked text:

Copy link into message below

Close menu

Please enter or paste the URL to the image here (please only use links to jpg/jpeg, png and gif images):

Copy image into message below

Close menu

Type author name or keywords to filter the list of references in this group (you can add a new citation under Bibliography):

No existing citations in Discussion Group

Wikify editor is a simple editor for wiki-style mark-up. It was written by MDPI for Sciforum in 2014. The rendering of the mark-up is based on Wiky.php with some tweaks. Rendering of mathematical equations is done with MathJax. Please send us a message for support or for reporting bugs.

Close menu

Please declare any conflicts of interest you may have with this paper, financial or otherwise.

I do not have a conflict of interest

I would like to declare a conflict of interest

Display my name on the website I want to get recognition for my comment on Publons

[what’s this?]. Link your accounts here

Captcha

Renew

I accept the following conditions:

Comments must follow the standards of professional discourse and should focus on the scientific content of the article. Insulting or offensive language, personal attacks and off-topic remarks will not be permitted. Comments must be written in English. Preprints reserves the right to remove comments without notice. Readers who post comments are obliged to declare any competing interests, financial or otherwise.

Notify me about updates to this article or when a peer-reviewed version is published.

Convalescent Plasma Therapy for Covid-19: State of the Art

Abstract

Subject Areas

Comments (1)